|
|
|
|
 |
|
SENSEX
|
 |
-359.40
|
-1.50%
|
|
23547.75
|
|
|
|
NIFTY
|
 |
-1092.06
|
-1.44%
|
|
74775.74
|
|
|
|
Nasdaq
|
 |
55.15
|
0.20%
|
|
26972.62
|
|
|
|
Nikkei 225
|
 |
1636.38
|
2.53%
|
|
66329.50
|
|
|
|
FTSE 100
|
 |
-16.70
|
-0.16%
|
|
10409.30
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Cohance Lifesciences Ltd.
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
BSE Code |
543064
|
|
ISIN Demat |
INE03QK01018
|
|
Book Value (Rs) |
117.11
|
|
|
NSE Code |
COHANCE
|
|
Dividend Yield % |
0.00
|
|
Market Cap (Rs) |
164924.69
|
|
|
TTM PE(x) |
72.11
|
|
TTM EPS(Rs) |
5.98
|
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
06-11 2018
|
|
Registered Office
|
215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri (East), Chakala Midc, Mumbai, Maharashtra-400093 .
|
|
ISINNO
|
INE03QK01018
|
|
Phone
|
022-61539999
|
|
E-mail
|
info@suvenpharm.com |
|
URL
|
www.cohance.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
|
|
Managing Director
|
|
|
Company Secretary
|
Sisir K Mishra
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|